MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd has been warned by U.S. health regulators for violating manufacturing standards at its Halol plant in India, even as it ...
** Shares of Sun Pharmaceutical Industries Ltd rise as much as 9.2 pct, their biggest intraday pct gain since April 2015, to 533.65 rupees ** Sun Pharma Advanced Research surges as much as 14 pct, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results